Search Results 1331-1340 of 15590 for Orange Peel tea

1. Study Evaluating Efficacy And Safety Of Octagam 10% In Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

   Cancer-associated myositis, defined as the diagnosis of myositis within 2 years of the diagnosis of cancer (except basal or squamous cell skin cancer or ...

2. Development of a Youth Healthy Living Program With Underserved Adolescents at Rochester Alternative Learning Center - Mayo Clinic

   Approximately one third of the children and adolescents in the United States are either overweight or obese. Childhood obesity disproportionately affects ...

3. A Study Of Elacestrant Versus Standard Endocrine Therapy In Women And Men With ER+,HER2-, Early Breast Cancer With High Risk Of Recurrence - Mayo Clinic

   ... skin cancer, superficial bladder cancer or carcinoma in situ of the cervix * Participants who have had more than a 6-month continuous interruption of prior ...

4. Anetumab Ravtansine And Atezolizumab In Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Cervical carcinoma in situ, non-melanoma skin cancer, superficial noninvasive bladder tumors, ductal carcinoma in situ (DCIS) or any previous cancer ...

5. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD) - Mayo Clinic

   Patients that are receiving anticoagulants (i.e., blood thinners) to prevent complications of skin biopsy. Exclusion Criteria - Late ADPKD Patients: Class 2 ...

6. Elevate CLL R/R: Study Of Acalabrutinib (ACP-196) Versus Ibrutinib In Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

   Prior malignancy, except for adequately treated lentigo maligna melanoma, non-melanomatous skin cancer, in situ cervical carcinoma or other malignancy treated ...

7. Safety And Efficacy Study Evaluating TRx0237 In Subjects With Behavioral Variant Frontotemporal Dementia (BvFTD) - Mayo Clinic

   ... skin cancer or Stage 1 prostate cancer) unless treatment has resulted in complete freedom from disease for at least 2 years; Prior intolerance or ...

8. Ruxolitinib In Combination With Pemetrexed/Cisplatin In Non Small Cell Lung Cancer - Mayo Clinic

   Current or previous other malignancy within 2 years of study entry, except cured basal or squamous cell skin cancer, superficial bladder cancer, prostate ...

9. A Study To Evaluate The Efficacy Of Cemsidomide + Dexamethasone In Participants With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   ... Skin changes (POEMS) Syndrome * Myelodysplastic syndrome (MDS). 3. Previously treated with cemsidomide. 4. Clinically significant impaired cardiac function ...

10. Evaluation Of The AMICUS Extracorporeal Photopheresis (ECP) System In Patients With Chronic Graft Versus Host Disease - Mayo Clinic

    Certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange. Participating Mayo Clinic locations. Study statuses ...